How many stocks does Nippon India Nifty Pharma ETF hold?

As of 2026-05-31, Nippon India Nifty Pharma ETF discloses 22 holdings.

How concentrated is Nippon India Nifty Pharma ETF?

Its top 10 holdings make up about 78% of the portfolio.

What is the largest holding in Nippon India Nifty Pharma ETF?

Sun Pharmaceutical Industries Limited is the largest disclosed holding at 21.4% of the portfolio.

Home / Discover / Fund

Nippon India Nifty Pharma ETF

Nippon India Mutual Fund As of 2026-05-31

Compare Run analysis

Holdings

Concentrated

Top 10 weight

78%

Concentration

Active share

Style

Equity

Asset allocation

Portfolio

1Sectors 16High-conviction bets 100%Top sector wt. -Cash

Market-cap allocation

Large cap54%

Mid cap38%

Small cap8%

Asset allocation

Asset mix not available.

Top holdings

Sun Pharmaceutical Industries LimitedEQUITY

21.4%

Divi's Laboratories LimitedEQUITY

9.5%

Dr. Reddy's Laboratories LimitedEQUITY

8.9%

Cipla LimitedEQUITY

8.9%

Lupin LimitedEQUITY

6.2%

Laurus Labs LimitedEQUITY

6.0%

Torrent Pharmaceuticals LimitedEQUITY

5.2%

Aurobindo Pharma LimitedEQUITY

4.5%

Glenmark Pharmaceuticals LimitedEQUITY

3.9%

Alkem Laboratories LimitedEQUITY

3.6%

AI Smart summary

Pros

Balanced across the metrics we track.

Cons

Compact 20-stock portfolio - higher single-stock impact.
High top-10 concentration (78%).
Concentrated in Pharmaceuticals & Biotechnology - watch sector risk.

Auto-generated from fund metrics. Educational only - not investment advice.

Peer comparison

Other funds in this category.

No peers found in this category.

Sector exposure

Full industry / sector breakdown aggregated from the fund's holdings.

Pharmaceuticals & Biotechnology100.0%